⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MDCX News
Medicus Pharma Ltd. Common Stock
Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead Development Dose
globenewswire.com
MDCX
Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company
globenewswire.com
MDCX
Form 8-K
sec.gov
MDCXW
MDCX
PFE
Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
accessnewswire.com
MDCX
Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom
globenewswire.com
MDCX
Medicus Pharma Receives UAE Department of Health (DOH) Authorization to proceed with Novel Prospective Genomics Guided Precision Medicine Study Evaluating Teverelix® in Women with Endometriosis
globenewswire.com
MDCX
Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome
globenewswire.com
MDCX
New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings
accessnewswire.com
BSIN
CAST
COCH
DVLT
LTRN
MDCX
VTIX
Medicus Pharma Receives Positive FDA Feedback and Central IRB Approval for Optimized Phase 2 Teverelix® Novel Study in Acute Urinary Retention
globenewswire.com
MDCX
New to The Street Show #760 Airs Tonight on Bloomberg Television Across the U.S. on Independence Day Featuring Sullivan & Cromwell’s Frank Aquila, Medicus Pharma, PetVivo, FreeCast and YY Group
accessnewswire.com
MDCX
CAST
YYGH
LTRN
DVLT
BSIN